Glucose transporter 1-expressing proinflammatory monocytes are elevated in combination antiretroviral therapy-treated and untreated HIV+ subjects

Journal of Immunology

Volumn 193, Issue 11, 2014, Pages 5595-5603

  Palmer, Clovis S ^a   Anzinger, Joshua J ^b   Zhou, Jingling ^a   Gouillou, Maelenn ^a   Landay, Alan ^c   Jaworowski, Anthony ^a,d   McCune, Joseph M ^e   Crowe, Suzanne M ^a,d  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b UNIVERSITY OF THE WEST INDIES   (Jamaica)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [N [7 NITROBENZ 2 OXA 1,3 DIAZOL 4 YL] AMINO] 2 DEOXYGLUCOSE; CD14 ANTIGEN; CD16 ANTIGEN; GLUCOSE DERIVATIVE; GLUCOSE TRANSPORTER 1; LACTIC ACID; MESSENGER RNA; UNCLASSIFIED DRUG; ANTIRETROVIRUS AGENT; AUTACOID; BIOLOGICAL MARKER; DRUG COMBINATION; GLUCOSE;

ADULT; ANAEROBIC GLYCOLYSIS; ARTICLE; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFLAMMATION; LYMPHOCYTE SUBPOPULATION; MALE; MONOCYTE; PROTEIN EXPRESSION; VIRUS LOAD; AGED; ANALOGS AND DERIVATIVES; AUSTRALIA; DRUG COMBINATION; DRUG EFFECTS; GENETICS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; UPREGULATION; VIROLOGY;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; AUSTRALIA; BIOLOGICAL MARKERS; DRUG COMBINATIONS; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HIV; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MONOCYTES; UP-REGULATION;

EID: 84912535396     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303092     Document Type: Article

References (53)

1. Antiretroviral Therapy Cohort Collaboration. 2008. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372: 293-299.
2. Hunt, P. W. 2012. HIV and inflammation: mechanisms and consequences. Curr. HIV/AIDS Rep. 9: 139-147.
3. Deeks, S. G. 2011. HIV infection, inflammation, immunosenescence, and aging. Annu. Rev. Med. 62: 141-155.
4. Sandler, N. G., and D. C. Douek. 2012. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat. Rev. Microbiol. 10: 655-666.
5. Raffatellu, M., R. L. Santos, D. E. Verhoeven, M. D. George, R. P. Wilson, S. E. Winter, I. Godinez, S. Sankaran, T. A. Paixao, M. A. Gordon, et al. 2008. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 14: 421-428.
6. Brenchley, J. M., D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, et al. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12: 1365-1371.
7. Hansson, G. K., and A. Hermansson. 2011. The immune system in atherosclerosis. Nat. Immunol. 12: 204-212.
8. Grivennikov, S. I., and M. Karin. 2011. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann. Rheum. Dis. 70 (Suppl. 1): i104-i108.
9. Raisz, L. G. 2005. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J. Clin. Invest. 115: 3318-3325.
10. Ziegler-Heitbrock, L., P. Ancuta, S. Crowe, M. Dalod, V. Grau, D. N. Hart, P. J. Leenen, Y. J. Liu, G. MacPherson, G. J. Randolph, et al. 2010. Nomenclature of monocytes and dendritic cells in blood. Blood 116: e74-e80.
11. Belge, K. U., F. Dayyani, A. Horelt, M. Siedlar, M. Frankenberger, B. Frankenberger, T. Espevik, and L. Ziegler-Heitbrock. 2002. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 168: 3536-3542.
12. Frankenberger, M., T. Sternsdorf, H. Pechumer, A. Pforte, and H. W. Ziegler-Heitbrock. 1996. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 87: 373-377.
13. Ziegler-Heitbrock, L. 2007. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J. Leukoc. Biol. 81: 584-592.
14. Blumenstein, M., P. Boekstegers, P. Fraunberger, R. Andreesen, H. W. Ziegler-Heitbrock, and G. Fingerle-Rowson. 1997. Cytokine production precedes the expansion of CD14+CD16+ monocytes in human sepsis: a case report of a patient with self-induced septicemia. Shock 8: 73-75.
15. Weiner, L. M., W. Li, M. Holmes, R. B. Catalano, M. Dovnarsky, K. Padavic, and R. K. Alpaugh. 1994. Phase I trial of recombinant macrophage colonystimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects. Cancer Res. 54: 4084-4090.
16. Calder, P. C. 1995. Fuel utilization by cells of the immune system. Proc. Nutr. Soc. 54: 65-82.
17. Calder, P. C., G. Dimitriadis, and P. Newsholme. 2007. Glucose metabolism in lymphoid and inflammatory cells and tissues. Curr. Opin. Clin. Nutr. Metab. Care 10: 531-540.
18. Maratou, E., G. Dimitriadis, A. Kollias, E. Boutati, V. Lambadiari, P. Mitrou, and S. A. Raptis. 2007. Glucose transporter expression on the plasma membrane of resting and activated white blood cells. Eur. J. Clin. Invest. 37: 282-290.
19. Korgun, E. T., R. Demir, P. Sedlmayr, G. Desoye, G. M. Arikan, P. Puerstner, M. Haeusler, G. Dohr, G. Skofitsch, and T. Hahn. 2002. Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes. Blood Cells Mol. Dis. 28: 152-159.
20. Dimitriadis, G., E. Maratou, E. Boutati, K. Psarra, C. Papasteriades, and S. A. Raptis. 2005. Evaluation of glucose transport and its regulation by insulin in human monocytes using flow cytometry. Cytometry A 64: 27-33.
21. Fu, Y., L. Maianu, B. R. Melbert, and W. T. Garvey. 2004. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol. Dis. 32: 182-190.
22. Fukuzumi, M., H. Shinomiya, Y. Shimizu, K. Ohishi, and S. Utsumi. 1996. Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1. Infect. Immun. 64: 108-112.
23. Palmer, C. S., M. Ostrowski, M. Gouillou, L. Tsai, D. Yu, J. Zhou, D. C. Henstridge, A. Maisa, A. C. Hearps, S. R. Lewin, et al. 2014. Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection. AIDS 28: 297-309.
24. Aukrust, P., N. B. Liabakk, F. Müller, E. Lien, T. Espevik, and S. S. Froland. 1994. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection-correlations to clinical, immunologic, and virologic parameters. J. Infect. Dis. 169: 420-424.
25. Riddler, S. A., E. Smit, S. R. Cole, R. Li, J. S. Chmiel, A. Dobs, F. Palella, B. Visscher, R. Evans, and L. A. Kingsley. 2003. Impact of HIV infection and HAART on serum lipids in men. JAMA 289: 2978-2982.
26. Hearps, A. C., A. Maisa, W. J. Cheng, T. A. Angelovich, G. F. Lichtfuss, C. S. Palmer, A. L. Landay, A. Jaworowski, and S. M. Crowe. 2012. HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS 26: 843-853.
27. Krishnan, S., E. M. Wilson, V. Sheikh, A. Rupert, D. Mendoza, J. Yang, R. Lempicki, S. A. Migueles, and I. Sereti. 2014. Evidence for innate immune system activation in HIV-1 infected elite controllers. J. Infect. Dis. 209: 931-939.
28. Ellery, P. J., E. Tippett, Y. L. Chiu, G. Paukovics, P. U. Cameron, A. Solomon, S. R. Lewin, P. R. Gorry, A. Jaworowski, W. C. Greene, et al. 2007. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178: 6581-6589.
29. Skrzeczyńska-Moncznik, J., M. Bzowska, S. Loseke, E. Grage-Griebenow, M. Zembala, and J. Pryjma. 2008. Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand. J. Immunol. 67: 152-159.
30. Hayes, M. P., J. Wang, and M. A. Norcross. 1995. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. Blood 86: 646-650.
31. Hayes, M. P., S. L. Freeman, and R. P. Donnelly. 1995. IFN-gamma priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and MRNA stability. Cytokine 7: 427-435.
32. Allen, J. B., H. L. Wong, P. M. Guyre, G. L. Simon, and S. M. Wahl. 1991. Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta. J. Clin. Invest. 87: 1773-1779.
33. Locher, C., G. Vanham, L. Kestens, M. Kruger, J. L. Ceuppens, J. Vingerhoets, and P. Gigase. 1994. Expression patterns of Fc gamma receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals. Clin. Exp. Immunol. 98: 115-122.
34. Thieblemont, N., L. Weiss, H. M. Sadeghi, C. Estcourt, and N. Haeffner-Cavaillon. 1995. CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 25: 3418-3424.
35. Autran, B., G. Carcelain, T. S. Li, C. Blanc, D. Mathez, R. Tubiana, C. Katlama, P. Debré, and J. Leibowitch. 1997. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277: 112-116.
36. Lichtfuss, G. F., W. J. Cheng, Y. Farsakoglu, G. Paukovics, R. Rajasuriar, P. Velayudham, M. Kramski, A. C. Hearps, P. U. Cameron, S. R. Lewin, et al. 2012. Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation. J. Immunol. 189: 1491-1499.
37. Dunham, R. M., I. Vujkovic-Cvijin, S. A. Yukl, M. J. Broadhurst, P. Loke, R. G. Albright, J. K. Wong, M. M. Lederman, M. Somsouk, P. W. Hunt, et al. 2014. Discordance between peripheral and colonic markers of inflammation during suppressive ART. J. Acquir. Immune Defic. Syndr.65: 133-141.
38. Fernandez, S., S. Tanaskovic, K. Helbig, R. Rajasuriar, M. Kramski, J. M. Murray, M. Beard, D. Purcell, S. R. Lewin, P. Price, and M. A. French. 2011. CD4+ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4+ T cells. J. Infect. Dis. 204: 1927-1935.
39. Moniuszko, M., A. Bodzenta-Lukaszyk, K. Kowal, D. Lenczewska, and M. Dabrowska. 2009. Enhanced frequencies of CD14++CD16+, but not CD14+ CD16+, peripheral blood monocytes in severe asthmatic patients. Clin. Immunol. 130: 338-346.
40. Sulicka, J., A. Surdacki, T. Mikolajczyk, M. Strach, B. Gryglewska, M. Ćwiklińska, W. Balwierz, T. Guzik, and T. K. Grodzicki. 2013. Elevated markers of inflammation and endothelial activation and increased counts of intermediate monocytes in adult survivors of childhood acute lymphoblastic leukemia. Immunobiology 218: 810-816.
41. Vereyken, E. J., M. D. Kraaij, C. C. Baan, F. Rezaee, W. Weimar, K. J. Wood, P. J. Leenen, and A. T. Rowshani. 2013. A shift towards pro-inflammatory CD16+ monocyte subsets with preserved cytokine production potential after kidney transplantation. PLoS ONE 8: e70152.
42. Han, J., B. Wang, N. Han, Y. Zhao, C. Song, X. Feng, Y. Mao, F. Zhang, H. Zhao, and H. Zeng. 2009. CD14(high)CD16(+) rather than CD14(low)CD16(+) monocytes correlate with disease progression in chronic HIV-infected patients. J. Acquir. Immune Defic. Syndr. 52: 553-559.
43. Rogacev, K. S., B. Cremers, A. M. Zawada, S. Seiler, N. Binder, P. Ege, G. Große-Dunker, I. Heisel, F. Hornof, J. Jeken, et al. 2012. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951patients referred for elective coronary angiography. J. Am. Coll. Cardiol. 60: 1512-1520.
44. Kuller, L. H., R. Tracy, W. Belloso, S. De Wit, F. Drummond, H. C. Lane, B. Ledergerber, J. Lundgren, J. Neuhaus, D. Nixon, et al INSIGHT SMART Study Group. 2008. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 5: e203.
45. Cotter, A. G., C. S. Satchell, J. A. O'halloran, E. R. Feeney, C. A. Sabin, and P. W. Mallon. 2011. High-density lipoprotein levels and 10-year cardiovascular risk in HIV-1-infected patients. AIDS 25: 867-869.
46. Danesh, J., P. Whincup, M. Walker, L. Lennon, A. Thomson, P. Appleby, A. Rumley, and G. D. Lowe. 2001. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation 103: 2323-2327.
47. Gordon, T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62: 707-714.
48. Funderburg, N. T., D. A. Zidar, C. Shive, A. Lioi, J. Mudd, L. W. Musselwhite, D. I. Simon, M. A. Costa, B. Rodriguez, S. F. Sieg, and M. M. Lederman. 2012. Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome. Blood 120: 4599-4608.
49. Saleh, M. N., S. J. Goldman, A. F. LoBuglio, A. C. Beall, H. Sabio, M. C. McCord, L. Minasian, R. K. Alpaugh, L. M. Weiner, and D. H. Munn. 1995. CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood 85: 2910-2917.
50. Nockher, W. A., and J. E. Scherberich. 1998. Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect. Immun. 66: 2782-2790.
51. Zimmermann, H. W., S. Seidler, J. Nattermann, N. Gassler, C. Hellerbrand, A. Zernecke, J. J. Tischendorf, T. Luedde, R. Weiskirchen, C. Trautwein, and F. Tacke. 2010. Functional contribution of elevated circulating and hepatic nonclassical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS ONE 5: e11049.
52. Raez, L. E., K. Papadopoulos, A. D. Ricart, E. G. Chiorean, R. S. Dipaola, M. N. Stein, C. M. Rocha Lima, J. J. Schlesselman, K. Tolba, V. K. Langmuir, et al. 2013. A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother. Pharmacol. 71: 523-530.
53. Loisel-Meyer, S., L. Swainson, M. Craveiro, L. Oburoglu, C. Mongellaz, C. Costa, M. Martinez, F. L. Cosset, J. L. Battini, L. A. Herzenberg, et al. 2012. Glut1-mediated glucose transport regulates HIV infection. Proc. Natl. Acad. Sci. USA 109: 2549-2554.